Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

3.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

13.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
13.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

3.5K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
3.5K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

7.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

63.9K
Overview
63.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of interferon on the steroidogenic functions and proliferation of immature porcine granulosa cells in culture.

Biology of reproduction·1992
Same author

Adult coronary artery disease probably due to childhood Kawasaki disease.

Lancet (London, England)·1992
Same author

Comparison of the survivals between bone marrow transplantation and chemotherapy for acute leukemia in first remission--a Japanese single institution study.

Leukemia & lymphoma·1992
Same author

Interactions between interferon gamma, tumour necrosis factor alpha, and interleukin-1 in modulating progesterone and oestradiol production by human luteinized granulosa cells in culture.

Human reproduction (Oxford, England)·1992
Same author

Human luteal cells express dipeptidyl peptidase IV on the cell surface.

The Journal of clinical endocrinology and metabolism·1992
Same author

Particular types of tumor cells have the capacity to convert transforming growth factor beta from a latent to an active form.

Cancer research·1992
Same journal

Foreword.

Immunology today·2020
Same journal

The origin and significance of anti-DNA antibodies.

Immunology today·2014
Same journal

Mutations of class II MHC molecules.

Immunology today·2014
Same journal

Antigen processing at the molecular level.

Immunology today·2014
Same journal

Are MHC class II-restricted cytotoxic T lymphocytes important?

Immunology today·2014
Same journal

Complement and the regulation of humoral immune responses.

Immunology today·2014
See all related articles
  1. Home
  3. Phenotypically And Functionally Distinct T-cell Subsets In Anti-tumor Responses.
  1. Home
  3. Phenotypically And Functionally Distinct T-cell Subsets In Anti-tumor Responses.

Related Experiment Video

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
07:49

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

19.7K

Phenotypically and functionally distinct T-cell subsets in anti-tumor responses.

T Hamaoka1, H Fujiwara1

  • 1Department of Oncogenesis, Institute for Cancer Research, Osaka University Medical School, 1-1-50, Fukushima, Fukushima-ku, 553, Japan.

Immunology Today
|October 26, 2014

View abstract on PubMed

Summary
This summary is machine-generated.

Tumor immunity involves helper T cells and cytolytic T cells, but their roles are debated. Recent studies suggest gamma interferon, produced by both cell types, nonspecifically inhibits tumor growth alongside cytolysis.

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.8K
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

8.2K

Related Experiment Videos

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
07:49

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

19.7K
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.8K
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

8.2K

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Immunology

Background:

  • The roles of helper T cells and cytolytic T cells in tumor rejection are debated.
  • Understanding the mechanisms of anti-tumor immunity is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To discuss recent experimental findings on the roles of T cells and gamma interferon in tumor cell rejection.
  • To clarify the relative importance of different immune cell populations and mechanisms in controlling tumor growth.

Main Methods:

  • Review of recent experimental data on T cell phenotypes and functions.
  • Analysis of lymphokine production by immune cells in the context of tumor rejection.

Main Results:

  • Tumor cell growth can be inhibited nonspecifically by gamma interferon.
  • Both cytotoxic T cells and helper T cells can produce gamma interferon.
  • Cytolysis also contributes to tumor cell rejection.

    • Conclusions:

    • Gamma interferon plays a significant, nonspecific role in inhibiting tumor growth.
    • Both cytotoxic and helper T cell subsets contribute to anti-tumor immunity through lymphokine production and direct cell killing.